-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Protagenic Therapeutics, Inc.\new quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2023.
- Protagenic Therapeutics, Inc.\new Operating Income (Loss) for the quarter ending September 30, 2024 was -$652K, a 54.5% increase year-over-year.
- Protagenic Therapeutics, Inc.\new Operating Income (Loss) for the twelve months ending September 30, 2024 was -$5.27M, a 32.7% decline year-over-year.
- Protagenic Therapeutics, Inc.\new annual Operating Income (Loss) for 2023 was -$4.53M, a 27.2% decline from 2022.
- Protagenic Therapeutics, Inc.\new annual Operating Income (Loss) for 2022 was -$3.56M, a 14.1% increase from 2021.
- Protagenic Therapeutics, Inc.\new annual Operating Income (Loss) for 2021 was -$4.14M, a 62.3% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)